Cytokinetics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/23/2024
Cytokinetics Stock Forecast and Price Target
In recent months, eleven notable analysts have provided yearlong price targets for Cytokinetics, with the average target coming in at $94.00. If it were to be achieved, this would result in a potential upside of approximately 41.8 percent from the most recent closing price in April, 2024. The high end is $122.00, and the low is $42.40. If you're interested in CYTK stock, it's important to compare it to other companies in the industry.
41.80% Upside
Cytokinetics Fair Value Forecast for 2023 - 2025 - 2030
Cytokinetics's Price has seen growth In the last four years, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $71.40 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.
Cytokinetics Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Cytokinetics's Revenue has fallen from $55.83M to $7.53M – a 86.51% decrease. In the next year, analysts believe that Revenue will reach $99.40M – an increase of 1220.05%. For the next seven years, the forecast is forRevenue to grow by 32433.07%.
.jpg)
Cytokinetics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Cytokinetics's EBITDA has increased by 430.67%, going from $-92.11M to $-488.80M. In the next year, 4 analysts estimate that Cytokinetics's EBITDA will decrease by 9.63%, reaching $-441.71M. According to professional forecasts, in 2030, Cytokinetics's EBITDA will decrease by 251.85%, reaching $742.24M.
Cytokinetics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Cytokinetics's EBIT has grown, increasing from $-93.94M to $-496.21M – an increase of 428.22%. According to 12 analysts, Cytokinetics's EBIT will fall by 15.76% in the next year, reaching $-418.00M. Professionals believe that By 2030, Cytokinetics's EBIT will fall to $1.31B – a 363.18% decrease from its current value.
Cytokinetics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Cytokinetics's EPS has seen growth In the last four years, going from $-1.97 to $0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach $-4.41 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.
.jpg)